Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation

Bone Marrow Transplantation

Volumn 25, Issue 4, 2000, Pages 377-383

  De Bruyn, C ^a   Delforge, A ^a   Lagneaux, L ^a   Bron, D ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Bone marrow; c kit; Cell cycle; Cord blood; Peripheral blood

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MITOSIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0033994517     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702145     Document Type: Article

References (38)

1. Arcese W, Aversa F, Bandini G et al. Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow. Haematologica 1998; 83: 159-182.
2. Rubinstein P, Carrier C, Scaradavoou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New Engl J Med 1998; 22: 1565-1577.
3. + cells an enhanced ex vivo expansion potential. Exp Hematol 1994, 22: 1264-1272.
4. Fritsch G, Stimpfl M, Kurz M et al. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 1996, 17: 169-178.
5. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89: 3919-3924.
6. Almici C, Carlo-Stella C, Wagner JE et al. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood. Leukemia 1997; 11: 2143-2149.
7. lo human marrow cells after in vitro cytokine exposure. Blood 1995; 85: 1480-1487.
8. Terstappen LWMM, Huang S, Safford M et al. Sequential generations of hematopoietic colonies derived from single nonlineage committed progenitor cells. Blood 1991; 77: 1218-1227.
9. Civin CI, Almeida-porada G, Lee MJ et al. Sustained, retransplantable, multilineage engraftment of highly purified adult human hone marrow stem cells in vivo. Blood 1996; 88: 4102-4109.
10. +CD38 cells in cord blood and bone marrow. Blood 1995, 86: 3745-3753.
11. +CD38 cord blood cells. J Hematother 1997; 6: 93-102.
12. Gordon MY, Dowding CR, Riley GP, Greaves MF. Characterisation of stroma-dependent blast colony forming cells in human marrow. J Cell Physiol 1987; 130: 150-156.
13. Gordon MY, Lewis JL, Grand FH et al. Phenotype and progeny of primitive adherent human hematopoietic progenitors. Leukemia 1996; 10: 1347-1353.
14. + purified cells from human cord blood and bone marrow. Stem Cells 1995; 13: 281-288.
15. Srour EF, Bregni M, Traycoff CM et al. Long term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood graft than in bone marrow but have a more limited ex vivo expansion potential. Blood Cells Mol Dis 1996; 22: 68-81.
16. + human hematopoietic progenitors from fetal liver, cord blood and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 1998; 26: 1034-1042.
17. Mielcarek M, Torok-Storb B. Phenotype and engraftment potential of cytokine-mobilized peripheral blood mononuclear cells. Curr Opin Hematol 1997; 4: 176-182.
18. + cells in thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 1996; 87: 1644-1653.
19. + cells in cord blood and in cytokine-mobilized blood. Br J Haematol 1996; 92: 255-262.
20. Uchida N, He D, Friera AM et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 1997; 89: 465-472.
21. + progenitors in G0/G1 versus S+G2/M phases of the cell cycle. Blood 1998; 92: 842-848.
22. + cells is not restricted to the more primitive subtraction. Leukemia 1998; 12: 571-577.
23. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997; 89: 1189-1196.
24. +, rhodamine 123 low phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia 1998; 12: 942-950.
25. Doi H, Inaba M, Yamamoto Y et al. Pluripotent hematopoietic stem cells are c-kit
26. +/c-kit
27. + cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Stem Cells 1997; 15: 73-81.
28. +c-kit cells: correlation between long-term culture-initiating cells and telomerase expression. Leukemia 1998; 12: 728-734.
29. + cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration. J Hematother 1997; 6: 563-573.
30. + cells from bone marrow and G-CSF-stimulated peripheral blood. Stem Cells 1998; 16: 49-53.
31. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997; 90: 1345-1364.
32. + hematopoietic progenitor cells: a five dimensional flow cytometry study. Haematologica 1998; 83: 587-592.
33. Kodama H, Nose M, Niida S et al. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 1994; 22: 979-984.
34. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641-2649.
35. Szilvassy SJ, Bass MJ, Van Zant G, Grimes B. Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 1999; 93: 1557-1566.
36. Alcorn MJ, Holyoake TL, Richmond L et al. CD34 positive cells isolated from cryopreserved peripheral blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996; 14: 1839-1847.
37. Holyoake TL, Alcorn MJ, Richmond L et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997; 19: 1095-1101.
38. Stiff P, Oldenberg D, Hsi E et al. Transplantation of ex vivo expanded cells grown in an Aastrom stromal-based perfusion bioreactor from small marrow aliquots (40 ml) produces durable hematopoietic reconstitution after ablative chemotherapy. Blood 1997; 90 (Suppl. 1): 395a.